More News

30 Jan 2018 AB Biosciences and Shire Enter Into Agreement for Development and Commercialization of AB Biosciences' PRIM Program for Potential Treatment of Autoimmune Diseases and Other Immune-Mediated Disorders
29 Jan 2018 Metrion Biosciences acquires rights to small molecule potassium channel inhibitors from Japan Tobacco Inc.
29 Jan 2018 Sanofi to acquire Ablynx for €3.9 billion
25 Jan 2018 Karyopharm Announces Agreement for Biogen to Acquire KPT-350 for the Treatment of Neurological and Neurodegenerative Conditions
25 Jan 2018 Novartis exclusively licenses first ophthalmology gene therapy in all markets outside the US, a milestone for patients with rare inherited vision loss
25 Jan 2018 Synpromics Announces New Partnership with UCL to Develop Novel Gene Therapies for Blood-Based Disorders
24 Jan 2018 CureVac Expands Intellectual Property Position That Significantly Improves Protein Expression for Its mRNA-Based Vaccines and Therapeutics
24 Jan 2018 Sorrento Therapeutics CAR-T Manufacturing Capacity Expanded With Opening of East Coast GMP Site in Addition to Primary West Coast Facility
24 Jan 2018 Bonti Announces Close of $15.5 Million Series C Funding and Appointment of David Ramsay as Chief Financial Officer
24 Jan 2018 Tmunity Therapeutics Raises $100 Million in Series A Financing to Advance Portfolio of Next-Generation T cell Immunotherapies to Transform the Treatment of Cancer
22 Jan 2018 Eureka Therapeutics Closes $60 Million in Series D Financing to Advance Proprietary ARTEMIS™ T Cell Receptor Platform for Safer T Cell Therapies
22 Jan 2018 BioCryst Pharmaceuticals and Idera Pharmaceuticals Announce Merger to Combine Capabilities to Serve More Patients With Rare Diseases
22 Jan 2018 Innovative Targeting Solutions Announces Research Agreement with Lilly
22 Jan 2018 Celgene Corporation to Acquire Juno Therapeutics, Inc., Advancing Global Leadership in Cellular Immunotherapy
22 Jan 2018 Sanofi to Acquire Bioverativ for $11.6 Billion
19 Jan 2018 Historic Deal Signed Between Panacea Biotec and Serum Institute of India
19 Jan 2018 Eisai enters into licensing agreement with Adlai Nortye for potential anticancer agent E7046 (prostaglandin E2 receptor type 4 antagonist)
18 Jan 2018 Sandoz announces exclusive global collaboration with Biocon on next-generation biosimilars
18 Jan 2018 X-Chem Enters Expanded Global Drug Discovery and Technology Transfer Collaboration with AstraZeneca
16 Jan 2018 Feldan Therapeutics and Green Cross LabCell Announce Start of Joint collaboration
11 Jan 2018 Adapsyn Bioscience Completes Financing to Advance its Small Molecule Natural Product Platform and Pipeline; Announces Research Collaboration with Pfizer Inc.
09 Jan 2018 Scancell to collaborate with BioNTech to investigate T cell receptor based therapeutics for the treatment of cancer
09 Jan 2018 Harbour BioMed Enters Agreement to Develop Fully Human Antibody Fragments for Innovative CAR-T Therapy
09 Jan 2018 Mallinckrodt Will Sell RECOTHROM® And PREVELEAK® To Baxter
09 Jan 2018 Teneobio Announces a Strategic Alliance with TESARO to Develop the Next Generation of Immuno-Oncology, Multispecific Antibodies

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up